.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Currently, India’s consumer healthcare market is growing rapidly.
Notably, Haleon has announced plans to establish its first-ever Haleon manufacturing plant in the country.
Specifically, the company will construct this greenfield facility in Pithampur, Madhya Pradesh.
Consequently, this major investment of ₹2,000 crore will significantly boost India's oral care infrastructure.
Historically, Haleon has relied entirely on third-party contract manufacturers in India.
However, the company is now shifting to a localized production model.
Specifically, this transition aims to build supply chain resilience and lower overall logistic costs.
Additionally, the new plant will help the company target 300 million Indian consumers by 2030.
Furthermore, India has now emerged as Haleon’s second-largest oral care market globally.
Undeniably, the Madhya Pradesh government has warmly welcomed this massive project.
Notably, the state’s Chief Minister, Dr. Mohan Yadav, virtually laid the foundation stone for the plant.
According to official reports, the facility will span over 40 acres in the Smart Industrial Park.
Moreover, the project will generate approximately 1,000 direct and indirect jobs.
Specifically, Haleon also aims to employ up to 30% women to promote workplace diversity.
Q1: What is the total investment for the new Haleon manufacturing plant?
Specifically, Haleon plans to invest approximately ₹2,000 crore to construct this first-of-its-kind oral health facility in India.
Q2: Where is the plant located, and when will it start operations?
Notably, the company is building the plant in Pithampur, Madhya Pradesh. Therefore, it expects the facility to begin operating within the next three years.
Q3: What products will the new facility manufacture?
Consequently, the site will focus on producing major oral healthcare products. Specifically, it will manufacture Sensodyne toothpaste to meet rising local demand.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Consumer healthcare giant Haleon is investing ₹2,000 crore to build its first greenfield manufacturing plant in Pithampur, MP, targeting oral health growth....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
